✦ LIBER ✦

O-270 Final results of a randomized phase II sequential two-line study of docetaxel (D) + cisplatin (CDDP) vs vinorelbine (V) + CDDP followed by crossover at progression in stage IV non-small cell lung cancer (NSCLC)

✍ Scribed by Douillard, Jean-Yves; Gervais, Radj; Dabouis, Gérard; Le Groumellec, Alain; D'Arlhac, Michel Michel; Spaeth, Dominique; Coudert, Bruno; Sun, Xu Shan; Clouet, Perrine; Ecstein-Fraïsse, Evelyne

Book ID: 118571660
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 185 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91928-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin/gemcitabine (CG) vs cisplatin/

Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (gv/iv) in advanced non-small cell lung cancer (NSCLC): final results of a Spanish lung cancer group phase III trial (GEPC/98-02)

✍ C. Camps; V. Alberola; M. Provencio; D. Isla; R. Rosell; C. Vadell; I. Bover; A. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB

9091 Activity, safety and compliance of

9091 Activity, safety and compliance of sequential chemotherapy with cisplatin (CDDP) plus oral vinorelbine (VNRos) followed by three-weekly docetaxel (DOC) as first-line treatment for advanced non-small cell lung cancer (NSCLC): a single-centre phase II study

✍ Teragni, C.; Palumbo, R.; Bernardo, A.; Strada, M.R.; Poggi, G.; Amatu, A.; Mont 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Preliminary results of a randomized stud

Preliminary results of a randomized study on first and second line chemotherapy strategy in stage IV non-small cell lung cancer (NSCLC), assessing docetaxel (D) and cisplatin (C) until progressive disease (PD) then vinorelbine (V) versus V-C until PD then D

✍ Douillard, J; Gervais, R; Lacroix, H; Le Groumellec, A; Spaeth, D; D'arlhac, M; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 227 KB

P-554 Randomized Phase II study of first

P-554 Randomized Phase II study of first-line docetaxel (D)/ gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC)—Final Results. A study by the NSW and Australian Lung Cancer Trials Group

✍ Pavlakis, N.; McCowatt, S.; Lewis, C.; Marx, G.; Abell, F.; Della-Fiorentina, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB